|
VAV3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69375624636814E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72528658026749E-12 |
| Normal-vs-Stage2 |
4.63689999952166E-07 |
| Normal-vs-Stage3 |
5.20670000447865E-08 |
| Normal-vs-Stage4 |
7.673600E-02 |
| Stage1-vs-Stage2 |
3.900800E-01 |
| Stage1-vs-Stage3 |
4.939600E-01 |
| Stage1-vs-Stage4 |
2.039400E-01 |
| Stage2-vs-Stage3 |
8.272600E-01 |
| Stage2-vs-Stage4 |
3.296400E-01 |
| Stage3-vs-Stage4 |
2.402600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64590563400679E-12 |
| Normal-vs-AfricanAmerican |
1.16599996324851E-09 |
| Normal-vs-Asian |
1.682800E-01 |
| Caucasian-vs-AfricanAmerican |
1.583650E-01 |
| Caucasian-vs-Asian |
2.390600E-01 |
| AfricanAmerican-vs-Asian |
4.953000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62470037423645E-12 |
| Normal-vs-Female |
1.44189999939925E-08 |
| Male-vs-Female |
2.215500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.88710158610661E-11 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
3.55319995648529E-09 |
| Normal-vs-Extreme_Obese |
1.743640E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.576400E-01 |
| Normal_Weight-vs-Obese |
1.343400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.593800E-02 |
| Extreme_Weight-vs-Obese |
4.202200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.233420E-01 |
| Obese-vs-Extreme_Obese |
5.092600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.4676999999973E-05 |
| Normal-vs-Age(41-60Yrs) |
3.20632409511745E-13 |
| Normal-vs-Age(61-80Yrs) |
5.87974113841483E-13 |
| Normal-vs-Age(81-100Yrs) |
9.32749988358239E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.611200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.203800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.930500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.218000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.630300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.698300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.80608869474008E-12 |
| Normal-VS-KIRP CIMP |
6.369800E-01 |
| Normal-VS-Unclassified PRCC |
1.42840184125248E-11 |
| Type1 PRCC-VS-Type2 PRCC |
5.828000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.533900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.519000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.390200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.563000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.759930E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48236978247951E-12 |
| Normal-vs-N1 |
9.219900E-04 |
| Normal-vs-N2 |
3.587200E-01 |
| N0-vs-N1 |
2.726400E-02 |
| N0-vs-N2 |
5.245200E-01 |
| N1-vs-N2 |
9.214600E-01 |
|
|
